Price to Sales ratio Analysis of CTi Biopharma Corp - Deep Dive
Latest FY PS
Period Ending - Dec-22
Very Poor PS
19.33
Period Ending - Dec-21
Very Poor PS
0
Growth
0 %
Trailing Twelve Months PS
Period Ending - Dec-22
Very Poor PS
14.29
PS Analysis of CTi Biopharma Corp
P/S Ratio of CTi Biopharma Corp with value of 14.29 indicates that stock price is high compared to sales of the company and may be overvalued. |
PS Ratio of CTIC has grown by 0 % Compared to previous Financial Year. |
PS Ratio with value of 153969 was highest in Year Dec-20 in last Five Years. |
PS Ratio with value of 0 was lowest in Year Dec-21 in last Five Years. |
Latest PS Ratio with value of 19.33 is lower than Average PS of 30833.14 in last five years. |
Other PS Related Info of CTIC that may interest you.
CTi Biopharma Corp Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
CTIC | 9.09 | 9.09 | 0 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
Poor Value Stock |
FY - Historical Price to Sales of CTi Biopharma Corp
Period | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
---|---|---|---|---|---|---|---|
PS | 19.33 | 0 | 153969 | 157.54 | 19.39 | 13.17 | 0.443 |
Change | 0 % | 97631.27 % | 712.59 % | 47.16 % | 2876.93 % | -72.02 % |
FY Chart of Price to Sales of CTi Biopharma Corp
Note : All Data Generated at the End of Trading Hours (EOD Data)